Evidence map›Paper›PMID 7479865›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

The activation domain of GAL4 protein mediates cooperative promoter binding with general transcription factors in vivo.

S Vashee, T Kodadek

Abstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Activation domain-mediated enhancement of activator binding to chromatin in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S VasheeDepartment of Chemistry and Biochemistry, University of Texas, Austin 78712, USA.
T Kodadek

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most proteins that activate RNA polymerase II-mediated transcription in eukaryotic cells contain sequence-specific DNA-binding domains and "activation" regions. The latter bind general transcription factors and/or coactivators and are required for high-level transcription. Their function in vivo is unknown. Since several activation domains bind the TATA-binding protein (TBP), TBP-associated factors, or other general factors in vitro, one role of the activation domain may be to facilitate promoter occupancy by supporting cooperative binding of the activator and general transcription factors. Using the GAL4 system of yeast, we have tested this model in vivo. It is demonstrated that the presence of a TATA box (the TBP binding site) facilitates binding of GAL4 protein to low- and moderate-affinity sites and that the activation domain modulates these effects. These results support the cooperative binding model for activation domain function in vivo.

Indexed as

Promoter Regions, GeneticSaccharomyces cerevisiae ProteinsTranscription, GeneticBase SequenceDNA-Binding ProteinsDNA, FungalFungal ProteinsHerpes Simplex Virus Protein Vmw65Models, GeneticMolecular Sequence DataProtein BindingStructure-Activity RelationshipTATA BoxTranscription FactorsDNA-Binding ProteinsDNA, FungalFungal ProteinsGAL4 protein, S cerevisiaeHerpes Simplex Virus Protein Vmw65Saccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID7479865
PMCPMC40676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.